Reviewed by Peptide Treatments Medical Advisory Board
Vilon: Research & Evidence
Early-Stage ResearchPublished research, clinical trial data, and evidence grading for Vilon across studied indications.
Back to Vilon overviewResearch Summary
Vilon has zero PubMed-indexed human studies, zero RCTs, and no Western clinical trials. All efficacy claims derive from Russian-language animal studies that have not been independently replicated. At only 2 amino acids, the fundamental question of how such a simple dipeptide could modulate complex immune function remains unresolved.
Evidence by Indication (2 indications)
| Indication | Tier | Trials | Summary |
|---|---|---|---|
| Immune modulation | Tier D | 0 | No human trials exist; animal studies from Russian sources report improved immune parameters but remain unverified |
| Thymus support | Tier D | 0 | Rodent data suggests thymic effects but no human translation has been attempted |
Graded using our evidence tier methodology.
Research Gap Score /10
Higher score = larger gap between therapeutic potential and available clinical evidence.